PepGen announces positive preclinical data for PGN-EDO53, PGN-EDO45 and PGN-EDO44, three novel duchenne muscular dystrophy candidates

November 15, 2022

Stay up to date

Get the latest on cutting edge developments from our enterprises straight to your inbox